Dyspnea News and Research

RSS

Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Allergies linked to heightened risk of long COVID, new review suggests

Systematic review indicates that pre-existing allergic conditions like asthma and allergic rhinitis may be linked to an increased risk of developing long COVID. Despite some evidence, the certainty remains low due to potential biases and confounding factors, highlighting the need for more rigorous research to determine the impact of these allergies on prolonged COVID-19 symptoms.

9 Nov 2023

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Dutch study finds SSRIs significantly alleviate post-COVID syndrome symptoms, offering promising treatment avenues and shedding light on neurobiological mechanisms at play.

5 Nov 2023

Avian flu decimates 5% of Peru's sea lions, sparking conservation alarm

Over 5,000 Peruvian sea lions, approximately 5% of Peru's population, succumbed to a mass mortality event linked to the avian influenza A(H5N1) virus, signaling an urgent need for research and conservation efforts to prevent further declines. The rapid spread of the virus among these colonially breeding mammals highlights potential risks of cross-species transmission and the necessity for heightened monitoring to avert new pandemics.

5 Nov 2023

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Comprehensive review unravels the complexities of long COVID, spanning pathophysiology to management strategies, and underscores the need for targeted therapies and early diagnosis.

5 Nov 2023

Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

Cardiopulmonary fitness, body composition, and persistent long COVID symptoms of individuals who had SARS-CoV-2 infections.

19 Oct 2023

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Symptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).

10 Oct 2023

Hospitalized COVID-19 patients face triple the risk of multiorgan damage, study reveals

Researchers in the U.K. find that patients hospitalized with COVID-19 face a higher medium-term risk of multiorgan abnormalities, revealed through multiorgan MRI scans. The study emphasizes the urgency for comprehensive post-hospitalization care, as these abnormalities are associated with persistent mental and physical health impairments.

25 Sep 2023

Occupational exposure to reinforced concrete production is associated with adverse respiratory health

The exposure to fine particulate matter (PM) in reinforced concrete production.

21 Sep 2023

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Researchers conducted a prospective cohort analysis over two years.

8 Sep 2023

Digital tech could unlock warning signs for imminent sudden cardiac arrest

A new study in Lancet Digital Health identifies early warning symptoms like chest pain and dyspnea that are moderately associated with imminent sudden cardiac arrest. The research suggests that future digital technologies could combine these symptoms with biometric data to more precisely predict and potentially prevent these life-threatening events.

3 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

Biomarkers unveil insights into post-COVID-19 syndrome variability

Researchers studied a prospective observation cohort of patients with post-coronavirus disease 2019 syndrome.

1 Sep 2023

How does COVID-19 influence your gut microbiota?

Researchers analyzed the fecal microbiota composition in COVID-19 patients in comparison to non-COVID-19 controls.

23 Aug 2023

Study explores the challenges of the clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease

A recent study evaluated the clinical, laboratory, and radiographic characteristics of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

16 Aug 2023

The safety of mesenchymal stem cell therapy for treating severe COVID-19

Normoxic-allogenic umbilical cord mesenchymal stem cells are safe and effective for treating severe COVID-19 patients.

7 Aug 2023

Overcoming challenges in COPD care: study focuses on pulmonary rehabilitation strategies

The different perspectives of respiratory care professionals.

4 Aug 2023

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Authors explored the impact of SARS-CoV-2 on thymus (T) cell activation.

1 Aug 2023

Smoking, physical inactivity, and other lifestyle factors increase the risk of multimorbidity

Researchers examine a wide range of lifestyle variables in the context of multimorbidity of chronic non-communicable illnesses.

31 Jul 2023

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Researchers assessed post-coronavirus disease 2019 (COVID-19) syndrome (PCS) prevalence and severity.

26 Jul 2023

Dyspnea News and Research

Further Reading

Allergies linked to heightened risk of long COVID, new review suggests

SSRIs show promise in easing post-COVID struggles, Dutch study reveals

Avian flu decimates 5% of Peru's sea lions, sparking conservation alarm

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Do overweight individuals exhibit reduced cardiopulmonary fitness after recovering from COVID-19?

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Hospitalized COVID-19 patients face triple the risk of multiorgan damage, study reveals

Occupational exposure to reinforced concrete production is associated with adverse respiratory health

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Digital tech could unlock warning signs for imminent sudden cardiac arrest

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Biomarkers unveil insights into post-COVID-19 syndrome variability

How does COVID-19 influence your gut microbiota?

Study explores the challenges of the clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease

The safety of mesenchymal stem cell therapy for treating severe COVID-19

Overcoming challenges in COPD care: study focuses on pulmonary rehabilitation strategies

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Smoking, physical inactivity, and other lifestyle factors increase the risk of multimorbidity

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News